LIU Chun-lian,QU Ling-hang,TU Ji-yuan,et al.Thoughts on Current Quality Standard of Atractylodis Rhizoma Based on Genuine Advantages of Traditional Chinese Medicine[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(03):212-219.
LIU Chun-lian,QU Ling-hang,TU Ji-yuan,et al.Thoughts on Current Quality Standard of Atractylodis Rhizoma Based on Genuine Advantages of Traditional Chinese Medicine[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(03):212-219. DOI: 10.13422/j.cnki.syfjx.20211765.
Thoughts on Current Quality Standard of Atractylodis Rhizoma Based on Genuine Advantages of Traditional Chinese Medicine
Atractylodis Rhizoma is a kind of commonly used clinical Chinese medicine (TCM), which was first recorded in
Shennong Bencaojing
(《神农本草经》). At that time, it was called "Zhu", which is the general name of Atractylodis Rhizoma and Atractylodis Macrocephalae Rhizoma. After Song dynasty, Atractylodis Rhizoma and Atractylodis Macrocephalae Rhizoma were separated. Atractylodis Rhizoma can be divided into
Atractylodes lancea
and
A. chinensis
. In history,
A. lancea
as authentic, that its quality is better than
A. chinensis
. However, the quality of Atractylodis Rhizoma was evaluated by the index component atractylodin in the 2020 edition of
Chinese Pharmacopoeia
. The general results showed that the content of atractylodin in
A. lancea
was low, even failed to meet the specified standard, and its content in
A. chinensis
was significantly higher than that in
A. lancea
. The results were inconsistent with the records of ancient books and documents, and the quality theory of "genuine medicine is the best". It could not reflect the quality advantage of genuine Atractylodis Rhizoma, and may even affect the clinical application and development momentum of genuine medicine. In short, the quality standard of TCM should not only conform to the historical experience, but also have the connotation of modern science and technology, which can stand the test of practice. Based on this, the author intends to sort out relevant laws and regulations, sort out the literature related to the authenticity, composition and efficacy of Atractylodis Rhizoma, and analyze the rationality of the current standard of Atractylodis Rhizoma by integrating the relevant records of historical classics and modern research results, so as to provide a basis for the improvement of the quality standard of Atractylodis Rhizoma.
LIU Y Q , ZHANG B X , CAI Q . Study on the pharmacodynamics and metabolomics of five medicinal species in Atractylodes DC. on rats with rheumatoid arthritis [J]. Biomed Pharmacother , 2020 , 131 : 110554 .
QU L H , XU Y Y , CAO G S , et al . Effects of Atractylodes oil on inflammatory response and serum metabolites in adjuvant arthritis rats [J]. Biomed Pharmacother , 2020 , 127 : 110130 .
General Situation of Modern Research of Chuanxiong Chatiaosan
Advance of Medical Plant Source and Technologies for Daodi Medicinal Material Planting, Processing and Quality Control in Shanxi Province
Evaluation of Effect of Rice-washed Water Bleaching Atractylodis Rhizoma on Spleen Deficiency Rats with Dampness Accumulation in Spleen by Multiple Indexes
HPLC Characteristic Fingerprints of Atractylodis Rhizoma Before and After Being Processed with Bran
Related Author
Guo-you WANG
Yun WANG
Xue ZHANG
De-peng LIU
Lan ZHANG
Ya GAO
Yin-lian MA
Cun ZHANG
Related Institution
College of Pharmacy,Henan University of Chinese Medicine
Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences
College of Pharmacy, Anhui University of Chinese Medicine, Heifei
College of Pharmacy, Yunnan University of Chinese Medicine
Daodi Herb Resources Development Engineering Research Center of Shanxi Province,School of Pharmacy,Shanxi Medical University